TP53 and cancer: However, in transformed contexts, such as in the presence of active oncogenes HER2, Ras, or mutant p53, increased HSF1 activity enables cancer cells to overcome senescence and cell cycle checkpoints and thereby enhances the capacity for tumorigenesis.